Schedule 13G ownership disclosure

GLYCOMIMETICS INC

Common Stock, $0.001 par value · CUSIP: 38000Q102

Event date: 2024-10-30

Filing-level shares
50,000.00
Percent of class
0.1%
  • Weinstein Benjamin

    Shares: 50,000.00 · Class: 0.1%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0002033801-24-000003
Form type
SCHEDULE 13G/A
Filer
CRESCENT BIOPHARMA, INC.
CIK
CIK 1253689
Filed
Nov 04, 2024
Reporting period
Oct 30, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub